C.T. Fitzpatrick
Vulcan Value Partners
Vulcan Value Partners AbbVie Inc stake
total: 273
Vulcan Value Partners ABBV trades
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 2
- Held since:
- 2015 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2016 Q1
According to 2026 Q2 report, Vulcan Value Partners doesn't hold any AbbVie Inc (ABBV) shares. To date, the estimated cost basis is nearly $59.19 for "buy" trades and estimated average "sell" price is $59.19. Vulcan Value Partners first purchased ABBV in 2014 Q2, initially acquiring 785 shares. Vulcan Value Partners later completely sold out the position and invested in AbbVie Inc again in 2015 Q4. Since the initial investment in AbbVie Inc (ABBV), Vulcan Value Partners has made 3 more transactions.
When did Vulcan Value Partners sell AbbVie Inc (ABBV)?
Vulcan Value Partners sold off the entire AbbVie Inc (ABBV) position in 2016 Q1.
When did Vulcan Value Partners buy AbbVie Inc (ABBV)?
Vulcan Value Partners first invested in AbbVie Inc (ABBV) in 2014 Q2 at the reported quarter-end price of $56.05 per share.
What's the cost basis of Vulcan Value Partners's ABBV stake?
The estimated cost basis for AbbVie Inc (ABBV) stake is around $59.19 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $59.19
- Weighted AVG sell price:
- $59.19
Vulcan Value Partners's historical trades in AbbVie Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2016 Q1
|
0.00%
|
$59.19
|
-100% (-3,700)
|
|||
|
2015 Q4
|
0.00%
|
$59.19
|
new
|
|||
|
2014 Q3
|
0.00%
|
$56.05
|
-100% (-785)
|
|||
|
2014 Q2
|
0.00%
|
$56.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.